ALPHA TRIBE

Alembic Pharmaceuticals LimitedUpdates, 26-06-2026: Press Release

26-06-2026 | 07:10 pm

Alembic Pharma secured USFDA final approval for Dapsone Gel, 5%, indicated for acne vulgaris. This approval enhances its US product portfolio, paving the way for market entry and potential revenue growth.

No comments yet. Be the first to comment!

All announcements from Alembic Pharmaceuticals Limited